- Home
- KRUS vs LXEO Comparison
KRUS vs LXEO Comparison
Compare KRUS & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KRUS | LXEO |
|---|---|---|
| Founded | 2008 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 649.3M | 663.5M |
| IPO Year | 2019 | 2023 |
Fundamental Metrics
Financial Performance| Metric | KRUS | LXEO |
|---|---|---|
| Price | $51.70 | $9.77 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 9 |
| Target Price | ★ $84.29 | $18.22 |
| AVG Volume (30 Days) | 326.6K | ★ 980.7K |
| Earning Date | 01-06-2026 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $282,763,000.00 | N/A |
| Revenue This Year | $19.06 | N/A |
| Revenue Next Year | $20.14 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 18.88 | N/A |
| 52 Week Low | $40.03 | $1.45 |
| 52 Week High | $106.60 | $10.38 |
Technical Indicators
Market Signals| Indicator | KRUS | LXEO |
|---|---|---|
| Relative Strength Index (RSI) | 49.39 | 57.77 |
| Support Level | $52.69 | $9.12 |
| Resistance Level | $55.50 | $9.71 |
| Average True Range (ATR) | 2.43 | 0.60 |
| MACD | 1.00 | 0.03 |
| Stochastic Oscillator | 69.59 | 81.77 |
Price Performance
Historical ComparisonAbout KRUS Kura Sushi USA Inc.
Kura Sushi USA Inc is a technology-enabled Japanese restaurant concept that provides guests with a distinctive dining experience by serving authentic Japanese cuisine through an engaging revolving sushi service model. The company operates a chain of sushi restaurants across the United States serving freshly prepared Japanese cuisine using high-quality ingredients that are free from artificial seasonings, sweeteners, colorings, and preservatives. The company operates a network of dine-in locations across the U.S. states and Washington, DC.
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.